American Academy of Pediatrics and other medical experts exclusively recommend to breastfeed the baby for first 6 months. Once you introduce baby to other foods it is recommended to breastfeed for at least first year of babys life. Taking medication while breastfeeding could be tricky as most drugs pass in breast milk. In this article we will evaluate Fluvoxamine Maleate Fluvoxamine Maleate 9 [hp_x] for its safety in breastfeeding.
What is Fluvoxamine Maleate Fluvoxamine Maleate 9 [hp_x] used for?
Fluvoxamine Maleate Tablets are indicated for the treatment of obsessions and compulsions in patients with obsessive compulsive disorder (OCD) (1). 1.1 Obsessive-Compulsive Disorder Fluvoxamine Maleate Tablets, USP are indicated for the treatment of obsessions and compulsions in patients with obsessive compulsive disorder (OCD), as defined in DSM-III-R or DSM-IV. The obsessions or compulsions cause marked distress, are time-consuming, or significantly interfere with social or occupational functioning. Obsessive compulsive disorder is characterized by recurrent and persistent ideas, thoughts, impulses or images (obsessions) that are ego-dystonic and/or repetitive, purposeful, and intentional behaviors (compulsions) that are recognized by the person as excessive or unreasonable. The efficacy of Fluvoxamine Maleate Tablets, USP was established in three trials in outpatients with OCD: two 10-week trials in adults, one 10-week trial in pediatric patients (ages 8-17). (See CLINICAL STUDIES .)
Is using Fluvoxamine Maleate Fluvoxamine Maleate 9 [hp_x] unsafe in breastfeeding? Can there be bad consequences for baby if I use it while breastfeeding?
As per our analysis Fluvoxamine Maleate Fluvoxamine Maleate 9 [hp_x] contains only one ingredient and that is Fluvoxamine maleate. We have analyzed Fluvoxamine maleate and it seems to be safe to use Fluvoxamine maleate while breastfeeding, that means usage of Fluvoxamine Maleate Fluvoxamine Maleate 9 [hp_x] shall be safe while breastfeeding. Below you can check more details of Fluvoxamine maleate usage in breastfeeding. We recommend you to go through provided detailed analysis as below take decision accordingly.
Statement of Manufacturer/Labeler about breastfeeding usage
8.3 Nursing Mothers As for many other drugs, fluvoxamine is secreted in human breast milk. The decision of whether to discontinue nursing or to discontinue the drug should take into account the potential for serious adverse effects from exposure to fluvoxamine in the nursing infant as well as the potential benefits of Fluvoxamine Maleate Tablets therapy to the mother.
Fluvoxamine maleate while Breastfeeding
CAS Number: 54739-18-3
It is excreted into breast milk in non-significant amount. Plasma level in infants from mother who receive Fluvoxamine is usually undetectable. Not effects on the infant's physical and psychomotor development at both short or long-term were found. Because there is less experience published than with other antidepressants of the same pharmacological group, it should be preferred the use of an alternative drug that is known to be safer in the neonatal period or prematurity. Galactorrhea has been observed but less frequently than with other antidepressants. In cases of treatment with xanthines (theophylline, caffeine) for apnea of prematurity, the plasma level of them should be monitored because Fluvoxamine is a strong inhibitor of activity of the Cytochrome P450-CYP1A2 which is responsible for metabolic elimination of xanthines. Women who use antidepressant medication during pregnancy are in need of more support for breastfeeding since they are at risk for early weaning.
Fluvoxamine maleate while Breastfeeding
CAS Number: 54739-18-3
Limited information indicates that maternal fluvoxamine doses of up to 300 mg daily produce low levels in breastmilk and would not be expected to cause any adverse effects in breastfed infants, especially if the infant is older than 2 months. One infant was reported to have an elevated serum level of fluvoxamine, but most who have been tested have undetectable serum levels. Another infant developed diarrhea, vomiting and stimulation after maternal initiation of fluvoxamine. A limited amount of long-term follow-up on growth and development has found no adverse effects in breastfed infants. Mothers taking an SSRI during pregnancy and postpartum may have more difficulty breastfeeding, although this might be a reflection of their disease state. These mothers may need additional breastfeeding support. Breastfed infants exposed to an SSRI during the third trimester of pregnancy have a lower risk of poor neonatal adaptation than formula-fed infants.
I already used Fluvoxamine Maleate Fluvoxamine Maleate 9 [hp_x] and meanwhile I breastfed my baby should I be concerned?
Fluvoxamine Maleate Fluvoxamine Maleate 9 [hp_x] is safe in breastfeeding and should not create any health problem for your baby but in case you feel any health issue associated with Fluvoxamine Maleate Fluvoxamine Maleate 9 [hp_x] you should contact your doctor or health care provider. Be it pregnancy or lactation you shall keep your doctor informed.
My health care provider has asked me to use Fluvoxamine Maleate Fluvoxamine Maleate 9 [hp_x], what to do?
Definitely, Fluvoxamine Maleate Fluvoxamine Maleate 9 [hp_x] is safe in lactation for baby. No wonder your doctor has recommended it.
If I am using Fluvoxamine Maleate Fluvoxamine Maleate 9 [hp_x], will my baby need extra monitoring?
No extra baby monitoring required while mother is using Fluvoxamine Maleate Fluvoxamine Maleate 9 [hp_x]
Who can I talk to if I have questions about usage of Fluvoxamine Maleate Fluvoxamine Maleate 9 [hp_x] in breastfeeding?
National Womens Health and Breastfeeding Helpline: 800-994-9662 (TDD 888-220-5446) 9 a.m. and 6 p.m. ET, Monday through Friday
National Breastfeeding Helpline: 0300-100-0212 9.30am to 9.30pm, daily
Association of Breastfeeding Mothers: 0300-330-5453
La Leche League: 0345-120-2918
The Breastfeeding Network supporter line in Bengali and Sylheti: 0300-456-2421
National Childbirth Trust (NCT): 0300-330-0700
National Breastfeeding Helpline: 1800-686-268 24 hours a day, 7 days a week
Telehealth Ontario for breastfeeding: 1-866-797-0000 24 hours a day, 7 days a week